Aldurazyme
Payments companies reported to CMS as associated with Aldurazyme. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aldurazyme, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aldurazyme
These are the largest totals companies reported as associated with Aldurazyme. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joseph Muenzer | Chapel Hill, NC | Pediatrics | $20,943.63 |
| Pramod Mistry | New Haven, CT | Gastroenterology (Internal Medicine) | $3,734.67 |
| Linda Spencer | Troy, MI | Nurse Practitioner | $229.12 |
| David Stockton | Detroit, MI | Internal Medicine | $194.32 |
| Carlos Prada | Chicago, IL | Clinical Genetics (M.D.) | $151.11 |
| Joshua Baker | Chicago, IL | Clinical Genetics (M.D.) | $151.11 |
| Mickey Kuo | Bethesda, MD | Clinical Genetics (M.D.) | $151.11 |
| Shoji Yano | Los Angeles, CA | Internal Medicine | $101.40 |
| Frances Velez-Bartolomei | San Juan, PR | Clinical Biochemical Genetics | $90.25 |
| Parul Jayakar | Miami, FL | Clinical Genetics (M.D.) | $86.06 |
Prescribed Aldurazyme?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.